Good morning :)
Place Order
Add to Watchlist

Strides Pharma Science Ltd

STAR

Strides Pharma Science Ltd

STAR
Health CarePharmaceuticals
SmallcapWith a market cap of ₹4,509 cr, stock is ranked 679
High RiskStock is 3.65x as volatile as Nifty
486.150.24% (-1.15)
486.150.24% (-1.15)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Health CarePharmaceuticals
SmallcapWith a market cap of ₹4,509 cr, stock is ranked 679
High RiskStock is 3.65x as volatile as Nifty

How to use scorecard? Learn more

Health CarePharmaceuticals
SmallcapWith a market cap of ₹4,509 cr, stock is ranked 679
High RiskStock is 3.65x as volatile as Nifty

Key Metrics

No LabelNo LabelPB RatioPB RatioDividend YieldDiv. Yield
-19.782.080.30%
Sector PESector PESector PBSector PBSector Div YldSctr Div Yld
44.465.110.70%

Forecast & Ratings

Detailed Forecast 
50%
Analysts have suggested that investors can buy this stock

from 2 analysts

Price

Price Upside

Earnings

Earnings Growth

Revenue

Rev. Growth

See Detailed Forecast

Company Profile

Strides Pharma Science is a vertically integrated global pharmaceutical company engaged in the development and manufacturing of active pharmaceutical ingredients and formulations, as well as biotech

Get more out of Tickertape, Go Pro!

Customise key metrics, see detailed forecasts, download stock data and more

Forecasts

Price

Revenue

Earnings

Income

Balance Sheet

Cash Flow

Income Statement

Industry refers to the sub-sector this company belongs to.

Lower than Industry Revenue Growth

A higher-than-industry revenue growth represents increased potential for the company to increase their market share

Over the last 5 years, revenue has grown at a yearly rate of 2.17%, vs industry avg of 8.45%

Decreasing Market Share

Market share is the percentage of an industry's total sales going to a particular company. It gives a general idea of the size of a company v/s its competitors

Over the last 5 years, market share decreased from 1.74% to 1.23%

Loading...

Financial YearFY 2015FY 2016FY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023TTM
Total Revenue2,099.432,961.593,097.803,534.852,545.662,909.443,518.843,259.233,935.443,920.02
Raw Materialssubtract574.641,612.381,432.251,286.651,189.201,167.291,686.501,407.041,629.553,626.50
Power & Fuel Costsubtract16.0277.1833.8751.3354.3964.4964.5871.5485.82
Employee Costsubtract172.06357.70419.16434.05329.44442.56550.15646.91732.02
Selling & Administrative Expensessubtract144.68323.35339.47409.34276.20338.51473.78577.98526.31
Operating & Other expensessubtract88.55154.1154.45313.14196.74525.2598.10798.52724.97
Depreciation/Amortizationsubtract64.03131.25126.15154.04117.39173.70206.29233.01243.25240.85
Interest & Other Itemssubtract47.44168.17183.10196.2479.29155.72150.07176.74261.14293.97
Taxes & Other Itemssubtract147.0128.92109.6025.55-21.605.5320.94-192.30-65.00-13.28
EPS137.2314.1043.2871.8935.674.0629.95-51.29-22.50-25.25
DPS104.524.844.361.943.0014.002.500.001.501.50
Payout ratio0.760.340.100.030.083.450.080.00-0.06

Company Updates

Annual Report and Investor Presentation updates mentioned here are as reported by the company to the exchange
FY 2015

Annual Report Unavailable

Investor Presentation

Sep 30PDF
FY 2016

Annual Report Unavailable

FY 2017

Annual Report Unavailable

FY 2018

Annual Report Unavailable

 

Peers & Comparison

Comparing 3 stocks from 
Health CarePharmaceuticals

Loading...

StockPE RatioPE RatioPB RatioPB RatioDiv. YieldDividend Yield
Strides Pharma Science Ltd-22.262.080.30%
Sun Pharmaceutical Industries Ltd35.105.010.93%
Cipla Ltd35.284.170.69%
Dr Reddy's Laboratories Ltd21.344.130.69%

Price Comparison

Compare STAR with any stock or ETF
Compare STAR with any stock or ETF
STAR
Loading...

Shareholdings

Promoter Holdings Trend

Total Promoter Holding

Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

High Pledged Promoter Holding

Lower pledged promoter holdings is considered better

A significant proportion of promoter holdings is pledged

Institutional Holdings Trend

Decreased Total Retail Holding

Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.

In last 3 months, retail holding in the company has decreased by 1.88%

Foreign Institutional Holding

Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock

In last 3 months, foreign institutional holding of the company has almost stayed constant

Tickertape Separator

Shareholding Pattern

Retail and OthersForeign InstitutionsOther Domestic InstitutionsMutual FundsTotal Promoter Holding27.78%13.67%6.23%17.25%35.06%

Dec 2022

Mar 2023

Jun 2023

Sep 2023

Shareholding History

JunSepDec '22MarJunSep21.23%21.82%18.99%18.85%16.73%17.25%

Mutual Funds Holding Trend

Mutual Fund Holding

Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock

In last 3 months, mutual fund holding of the company has almost stayed constant

Top 5 Mutual Funds holding Strides Pharma Science Ltd




Funds (Top 5)Market-cap heldWeight3M holding changePortfolio rank
(3M change)
Aditya Birla Sun Life Flexi Cap Fund - Growth - Direct Plan

Growth
3.0228%0.80%0.03%37/74 (+1)
Quant Small Cap Fund - Growth - Direct Plan

Growth
2.6038%1.05%-0.28%22/125 (-6)
SBI Long Term Equity Fund - Growth - Direct Plan

Growth
2.1410%0.61%-0.01%30/72 (0)

Compare 3-month MF holding change on Screener

Insider Trades & Bulk Deals

Loading...

smallcases

Looks like this stock is not in any smallcase yet.

Events

Dividend Trend

No dividend trend available

Dividends

Corp. Actions

Announcements

Legal Orders

Upcoming Dividends

No upcoming dividends are available

Past Dividends

Cash Dividend

Ex DateEx DateAug 4, 2023

Final
Final | Div/Share: ₹1.50

Dividend/Share

1.50

Ex DateEx Date

Aug 4, 2023

Cash Dividend

Ex DateEx DateAug 5, 2021

Final
Final | Div/Share: ₹2.50

Dividend/Share

2.50

Ex DateEx Date

Aug 5, 2021

Cash Dividend

Ex DateEx DateJul 24, 2020

Final
Final | Div/Share: ₹2.00

Dividend/Share

2.00

Ex DateEx Date

Jul 24, 2020

Cash Dividend

Ex DateEx DateAug 22, 2019

Interim
Interim | Div/Share: ₹12.00

Dividend/Share

12.00

Ex DateEx Date

Aug 22, 2019

Cash Dividend

Ex DateEx DateJul 19, 2019

Final
Final | Div/Share: ₹3.00

Dividend/Share

3.00

Ex DateEx Date

Jul 19, 2019